Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Tumori|June 25, 2021
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case reportGinevra Lolli, Beatrice Casadei, Cinzia Pellegrini, et al.
Chemotherapy|May 10, 2022
Hepatosplenic T-Cell Non-Hodgkin Lymphoma Cured with Tandem Autologous and Allogeneic Stem Cell TransplantationGinevra Lolli, Beatrice Casadei, Vittorio Stefoni, et al.
Scientific Reports|February 3, 2022
Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitorsLisa Argnani, Beatrice Casadei, Carla Pelusi, et al.
Hematological Oncology|January 15, 2019
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapiesLaura Nanni, Alice Morigi, Beatrice Casadei, et al.
Chemotherapy|November 1, 2023
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case ReportSabrina Zoli, Cinzia Pellegrini, Beatrice Casadei, et al.
Chemotherapy|June 13, 2023
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case ReportMarianna Gentilini, Beatrice Casadei, Alice Morigi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patientsGianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, et al.
Journal of Clinical Medicine|December 24, 2021
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life ExperienceAlessandro Broccoli, Lisa Argnani, Alice Morigi, et al.
BMC Health Services Research|January 23, 2024
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory studyMaria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, et al.
The Oncologist|February 10, 2024
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous TransplantationAlessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, et al.
Pageof 10